Symptom clusters in outpatients with cancer using different dimensions of the symptom experience
- PMID: 35543816
- PMCID: PMC10792845
- DOI: 10.1007/s00520-022-07125-z
Symptom clusters in outpatients with cancer using different dimensions of the symptom experience
Abstract
Purpose: Relatively few studies have evaluated for symptom clusters across multiple dimensions. It is unknown whether the symptom dimension used to create symptom clusters influences the number and types of clusters that are identified. Study purposes were to describe ratings of occurrence, severity, and distress for 38 symptoms in a heterogeneous sample of oncology patients (n = 1329) undergoing chemotherapy; identify and compare the number and types of symptom clusters based on three dimensions (i.e., occurrence, severity, and distress); and identify common and distinct clusters.
Methods: A modified version of the Memorial Symptom Assessment Scale was used to assess the occurrence, severity, and distress ratings of 38 symptoms in the week prior to patients' next cycle of chemotherapy. Symptom clusters for each dimension were identified using exploratory factor analysis.
Results: Patients reported an average of 13.9 (±7.2) concurrent symptoms. Lack of energy was both the most common and severe symptom while "I don't look like myself" was the most distressing. Psychological, gastrointestinal, weight gain, respiratory, and hormonal clusters were identified across all three dimensions. Findings suggest that psychological, gastrointestinal, and weight gain clusters are common while respiratory and hormonal clusters are distinct.
Conclusions: Psychological, gastrointestinal, weight gain, hormonal, and respiratory clusters are stable across occurrence, severity, and distress in oncology patients receiving chemotherapy. Given the stability of these clusters and the consistency of the symptoms across dimensions, the use of a single dimension to identify these clusters may be sufficient. However, comprehensive and disease-specific inventories need to be used to identify distinct clusters.
Keywords: Cancer; Chemotherapy; Symptom clusters; Symptoms.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Competing Interests
The authors have no relevant financial or non-financial interests to disclose.
Similar articles
-
Symptom clusters in oncology outpatients: stability and consistency across a cycle of chemotherapy.BMJ Support Palliat Care. 2024 Jan 8;13(e3):e1198-e1211. doi: 10.1136/spcare-2022-003785. BMJ Support Palliat Care. 2024. PMID: 36446517 Free PMC article.
-
Stability and consistency of symptom clusters in younger versus older patients receiving chemotherapy.BMC Geriatr. 2024 Feb 16;24(1):164. doi: 10.1186/s12877-024-04755-2. BMC Geriatr. 2024. PMID: 38365584 Free PMC article.
-
Differences in symptom clusters identified using symptom occurrence rates versus severity ratings in patients with breast cancer undergoing chemotherapy.Eur J Oncol Nurs. 2017 Jun;28:122-132. doi: 10.1016/j.ejon.2017.04.001. Epub 2017 Apr 26. Eur J Oncol Nurs. 2017. PMID: 28478849 Free PMC article.
-
A review of the literature on symptom clusters in studies that included oncology patients receiving primary or adjuvant chemotherapy.J Clin Nurs. 2018 Feb;27(3-4):516-545. doi: 10.1111/jocn.14057. Epub 2017 Oct 10. J Clin Nurs. 2018. PMID: 28859255 Free PMC article. Review.
-
Symptom clusters in patients receiving chemotherapy: A systematic review.BMJ Support Palliat Care. 2022 Mar;12(1):10-21. doi: 10.1136/bmjspcare-2021-003325. Epub 2021 Dec 17. BMJ Support Palliat Care. 2022. PMID: 34921000 Free PMC article.
Cited by
-
Identifying symptom cluster in cancer patients undergoing chemotherapy-in Vietnam: A cross-sectional study.PLoS One. 2024 Sep 20;19(9):e0307725. doi: 10.1371/journal.pone.0307725. eCollection 2024. PLoS One. 2024. PMID: 39302979 Free PMC article.
-
Features and Differences in Core Symptom Clusters in Home-Based Hospice Patients With Advanced Cancer: A Network Analysis.Cancer Med. 2024 Nov;13(21):e70370. doi: 10.1002/cam4.70370. Cancer Med. 2024. PMID: 39494586 Free PMC article.
-
Impact of Multimorbidity on Symptom Burden and Symptom Clusters in Patients Receiving Chemotherapy.Cancer Med. 2025 Feb;14(3):e70418. doi: 10.1002/cam4.70418. Cancer Med. 2025. PMID: 39910913 Free PMC article.
-
Symptom clusters and networks analysis in acute-phase stroke patients: a cross-sectional study.Sci Rep. 2025 Jan 20;15(1):2539. doi: 10.1038/s41598-024-84642-3. Sci Rep. 2025. PMID: 39833271 Free PMC article.
-
Multidimensional Predictors of Cancer-Related Fatigue Based on the Predisposing, Precipitating, and Perpetuating (3P) Model: A Systematic Review.Cancers (Basel). 2023 Dec 17;15(24):5879. doi: 10.3390/cancers15245879. Cancers (Basel). 2023. PMID: 38136423 Free PMC article. Review.
References
-
- Dodd M, Miaskowski C, Paul S (2001) Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28(3):465–470. - PubMed
-
- Given CW, Given B, Azzouz F, Kozachik S, Stommel M (2001) Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients. J Pain Symptom Manage 21(6):456–466. - PubMed